Thrombocytopenia in malaria : who cares?

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.creatorLacerda, Marcus Vinícius Guimarães de-
Autor(es): dc.creatorMourão, Maria Paula Gomes-
Autor(es): dc.creatorCoelho, Helena Cristina Cardoso-
Autor(es): dc.creatorSantos, João Barberino-
Data de aceite: dc.date.accessioned2024-10-23T16:07:47Z-
Data de disponibilização: dc.date.available2024-10-23T16:07:47Z-
Data de envio: dc.date.issued2017-12-07-
Data de envio: dc.date.issued2017-12-07-
Data de envio: dc.date.issued2011-08-
Fonte completa do material: dc.identifierhttp://repositorio.unb.br/handle/10482/27974-
Fonte completa do material: dc.identifierhttps://dx.doi.org/10.1590/S0074-02762011000900007-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/capes/900517-
Descrição: dc.descriptionDespite not being a criterion for severe malaria, thrombocytopenia is one of the most common complications of both Plasmodium vivax and Plasmodium falciparum malaria. In a systematic review of the literature, platelet counts under 150,000/mm³ ranged from 24-94% in patients with acute malaria and this frequency was not different between the two major species that affected humans. Minor bleeding is mentioned in case reports of patients with P. vivax infection and may be explained by medullary compensation with the release of mega platelets in the peripheral circulation by megakaryocytes, thus maintaining a good primary haemostasis. The speculated mechanisms leading to thrombocytopenia are: coagulation disturbances, splenomegaly, bone marrow alterations, antibody-mediated platelet destruction, oxidative stress and the role of platelets as cofactors in triggering severe malaria. Data from experimental models are presented and, despite not being rare, there is no clear recommendation on the adequate management of this haematological complication. In most cases, a conservative approach is adopted and platelet counts usually revert to normal ranges a few days after efficacious antimalarial treatment. More studies are needed to specifically clarify if thrombocytopenia is the cause or consequence of the clinical disease spectrum.-
Descrição: dc.descriptionFaculdade de Medicina (FMD)-
Formato: dc.formatapplication/pdf-
Idioma: dc.languageen-
Publicador: dc.publisherInstituto Oswaldo Cruz, Ministério da Saúde-
Direitos: dc.rightsAcesso Aberto-
Direitos: dc.rightsMemórias do Instituto Oswaldo Cruz - All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License (CC BY NC 4.0). Acesso em: 19 mar. 2021.-
Palavras-chave: dc.subjectPlasmodium falciparum-
Palavras-chave: dc.subjectPlasmodium vivax-
Palavras-chave: dc.subjectMalária-
Palavras-chave: dc.subjectPlaquetas-
Título: dc.titleThrombocytopenia in malaria : who cares?-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional – UNB

Não existem arquivos associados a este item.